“Analysts Predict Up to 400% Spike for These 2 ‘Strong Buy’ Penny Stocks”
January 26, 2026
“…Acumen Pharmaceuticals (ABOS)…
With a major catalyst ahead and ABOS shares trading at $1.98, Stifel’s 5-star analyst Paul Matteis thinks now is the right time to make a move… To this end, Matteis rates ABOS a Buy, and his $10 price target points to a massive 405% upside over the next year. (To watch Matteis’ track record, click here)…
SAB BIO (SABS)…
The second penny stock we’re diving into, SAB BIO, is a clinical-stage biotech company focused on advancing new treatments for autoimmune diseases – particularly Type 1 diabetes… [Because of the progress the company is making] Yee rates SABS a Buy with a $7 price target, implying upside of 73% over the next year. (To watch Yee’s track record, click here)…”
https://finance.yahoo.com/news/analysts-predict-400-spike-2-110500020.html
Just to be clear I am not recommend these stocks. Yahoo is. I have a lot of experience with penny stocks. Thats mainly what I trade. I can tell you from experience be careful when listening to price targets for penny stocks. The vast majority of the time these “price targets” are achieved though reverse stock splits. Long store shore its fake. This should be illegal in my opinion. I see it as fraud. The price didnt increase the number of stocks decreased.